Paul Alpern Sells 4,000 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) VP Paul Alpern sold 4,000 shares of Arteris stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $30.04, for a total value of $120,160.00. Following the transaction, the vice president owned 70,733 shares of the company’s stock, valued at approximately $2,124,819.32. This represents a 5.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Arteris Trading Up 2.2%

Arteris stock opened at $31.62 on Friday. The firm has a market cap of $1.46 billion, a PE ratio of -40.03 and a beta of 1.96. Arteris, Inc. has a 12 month low of $8.42 and a 12 month high of $50.26. The stock’s 50 day simple moving average is $36.06 and its two-hundred day simple moving average is $26.16. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17.

Arteris (NASDAQ:AIPGet Free Report) last posted its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The firm had revenue of $24.13 million for the quarter, compared to analysts’ expectations of $23.48 million. Analysts anticipate that Arteris, Inc. will post -0.58 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Jefferies Financial Group lifted their price objective on shares of Arteris from $16.00 to $35.00 and gave the company a “hold” rating in a report on Wednesday, May 13th. Rosenblatt Securities raised their target price on Arteris from $20.00 to $38.00 and gave the company a “buy” rating in a research report on Wednesday, May 13th. TD Cowen lifted their price target on Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Roth Capital initiated coverage on Arteris in a report on Tuesday. They issued a “buy” rating and a $40.00 price target for the company. Finally, Weiss Ratings downgraded Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Arteris has an average rating of “Moderate Buy” and a consensus price target of $38.50.

Get Our Latest Stock Analysis on Arteris

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

  • Positive Sentiment: Arteris reported second-quarter revenue of $24.13 million, above the $23.48 million analyst consensus. More importantly, the company forecast third-quarter revenue of $24.0 million to $25.0 million and full-year 2026 revenue of $95.0 million to $98.0 million, both ahead of consensus estimates of $23.5 million and $94.2 million, respectively. The outlook suggests continued demand for Arteris’ semiconductor interconnect and system IP products. Arteris financial results and guidance
  • Positive Sentiment: Roth Capital initiated coverage with a Buy rating and a $40 price target, while other analysts also maintain bullish targets. The new coverage adds support to the investment case and implies meaningful upside from recent trading levels. Roth Capital coverage
  • Neutral Sentiment: Arteris appointed Saurabh Sinha as chief financial officer. The leadership change may improve investor focus on financial execution, although the announcement itself provides limited information about near-term earnings effects. Arteris CFO appointment
  • Negative Sentiment: Second-quarter adjusted EPS was a loss of $0.10, missing the expected loss of $0.04 by $0.06. The larger-than-expected loss highlights ongoing profitability pressure despite the revenue beat. Arteris quarterly earnings
  • Negative Sentiment: Several insiders reported sales, including CEO K. Charles Janac, Director Saiyed Atiq Raza, major shareholder Bayview Legacy, and Vice President Paul Alpern. While the sales represent relatively small portions of their remaining holdings in some cases, the concentration of insider selling could weigh on sentiment. Arteris insider selling

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its holdings in shares of Arteris by 33.7% during the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock worth $56,000 after buying an additional 290 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Arteris in the second quarter worth about $32,000. State of Wyoming purchased a new position in shares of Arteris in the second quarter worth about $165,000. Royal Bank of Canada raised its holdings in Arteris by 366.7% in the 1st quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock valued at $66,000 after acquiring an additional 3,161 shares during the last quarter. Finally, BNP Paribas Financial Markets raised its holdings in Arteris by 75.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after acquiring an additional 2,595 shares during the last quarter. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Further Reading

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.